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INTRODUCTION
Polysomnography (PSG) is the current gold standard for 
defining the presence and severity of obstructive sleep apnea 
(OSA).1,2 In 2007, the American Academy of Sleep Medicine 
(AASM) published revised guidelines for the scoring of PSG, 
including the definitions of respiratory events and sleep stages.3 
Since its publication, these guidelines have been increasingly 
adopted internationally for scoring PSGs.
Using the AASM guidelines, a previous retrospective study 
found substantial interrater agreement in the scoring of sleep 
stages among six scorers from three sleep centers.4 A major 
revision within the new guidelines is a recommended defini-
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tion for a hypopnea that incorporates a ≥ 4% oxyhemoglobin 
desaturation associated with the respiratory event.3 A previ-
ous multi-center study showed that the interrater agreement 
for scoring respiratory events by three sleep technologists at 
one centralized scoring center was excellent when respiratory 
indices during sleep were defined by association with an oxy-
hemoglobin desaturation rather than by presence of associated 
electroencephalographic (EEG) arousals.5
Although centralized scoring of PSGs in multicenter stud-
ies has been shown to be an excellent approach in standard-
izing their analysis,5 it is also more resource-intensive in terms 
of infrastructure (sharing of PSGs and server space) and ad-
equate scoring personnel, particularly in research involving 
patients who are to have PSGs for clinical reasons. The need 
for these additional resources is likely to be magnified where 
the multicenter studies include different countries in various 
continents. Such studies will be increasingly needed with pro-
liferation of large multicenter clinical trials and studies of the 
genetics of sleep disorders. One alternative approach would be 
local scoring of the sleep studies by experienced technologists 
in the sleep centers where the PSGs were acquired as is done 
in routine clinical practice. However, the inter-rater agreement 
of scoring respiratory events and sleep stages using the AASM 
guidelines among international sleep centers is unknown.
A commentary on this article appears in this issue on page 465.
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We sought to determine the agreement of scoring respiratory 
events and sleep stages in the nine center-members of the Sleep 
Apnea Genetics International Consortium (SAGIC) [http://
www.med.upenn.edu/sleepctr/SAGIC.shtml]. Our primary hy-
pothesis was that there would be good agreement in the scoring 
of the apnea-hypopnea index (AHI) among experienced scorers 
in the SAGIC centers using the new AASM definitions.
METHODS
The SAGIC centers are located in the following cities: Perth, 
Australia; Sydney, Australia; São Paulo, Brazil; Grenoble, 
France; Berlin, Germany; Reykjavik, Iceland; Taipei, Taiwan; 
and Columbus, Ohio and Philadelphia, Pennsylvania in the 
United States of America. The study was approved by the In-
stitutional Review Board of The Ohio State University Medical 
Center. Informed consent was waived for this study given that 
PSG was previously recorded and deidentified.
Polysomnography
Fifteen previously recorded attended, in-laboratory PSGs in 
the Columbus, Ohio site were chosen by a SAGIC investigator 
(UM). The studies were randomly selected from a database of 
clinical PSGs recorded during one quarter, in order to represent 
a wide spectrum of OSA severity based on AHI: AHI 0-20/h: 
n = 5; AHI 21-30/h: n = 5; AHI > 30/h: n = 5. Once the required 
number of studies in each level of OSA severity has been select-
ed, no further studies in the specified AHI range were included. 
Exclusion criteria included split-night and titration studies, 
those done while on oxygen supplementation, and less than 4 
h of recording time. Once the 15th sleep study was selected, no 
further sleep studies were evaluated. During this process, there 
were no studies excluded on the basis of poor signal quality.
All PSGs were originally recorded using an N-7000 amplifi-
er (Embla Systems, LLC, Ontario, Canada). The sampling rates 
of the channels were: EEG, electrooculogram (EOG), electro-
myogram (EMG), electrocardiogram (ECG), snore, thermocou-
ple airflow, and nasal pressure: 200 Hz; chest and abdominal 
movement: 50 Hz; and pulse oximetry: 10 Hz. The pulse oxim-
eter (Nonin Medical, Inc, Plymouth, MN) used in acquiring the 
PSGs used an averaging algorithm of 3 sec or faster for pulse 
rates of 60 beats per min or greater. The PSGs were deiden-
tified and then converted into European Data Format (EDF). 
EDF conversion removed all previous scoring of sleep stages, 
respiratory events, and sleep technologist notations because the 
format contains only the biosignals and calibration information.
Scoring
At each SAGIC site, the studies in EDF format were im-
ported into the local software used for scoring. The scoring 
software included Remlogic (Embla Systems, LLC, Ontario, 
Canada) [Grenoble, Berlin, and São Paulo, Brazil sites]; Com-
pumedics (Compumedics Limited, Victoria, Australia) [Perth, 
Sydney, and Taipei, Taiwan sites]; Sandman (Embla Systems, 
LLC, Ontario, Canada) [Philadelphia, PA site]; Rembrandt 
(Embla Systems, LLC, Ontario, Canada) [Columbus, OH site]; 
and Somnologica (Embla Systems, LLC, Ontario, Canada) 
[Reykjavik, Iceland site]. A protocol including a review of the 
AASM guidelines on scoring of sleep and respiratory events 
(in Microsoft Power Point) was provided to one experienced 
scorer from each SAGIC site who performed the scoring of the 
imported PSGs. All scorers have at least 5 yr of experience in 
scoring clinical PSGs and were designated by the investigator 
at each site. The recording start time, recording end time, lights-
off time, and lights-on time were provided for each study. The 
channel names of the different signals as well as their deriva-
tions were also provided: EEG: F4, C4, O2 all referenced to 
M1 and F3, C3, O1 all referenced to M2; EOG: E1-M2, E2-
M2; chin EMG; snore channels, nasal pressure; thermocouple 
oronasal airflow; chest and abdominal movements; oxyhemo-
globin saturation and plethysmographic signal by pulse oxim-
etry; electrocardiogram; and leg EMG. Each 30-sec epoch was 
manually scored for sleep stage, apneas, hypopneas, and arous-
als using the AASM recommended criteria.3 Briefly, an apnea 
is scored when all of the following criteria are met: a drop in 
thermal sensor excursion by ≥ 90% of baseline, the duration of 
the event lasts at least 10 sec, and at least 90% of the event’s 
duration meets the amplitude reduction criteria. An apnea is 
classified as obstructive if it is associated with continued or in-
creased respiratory effort throughout the entire period of absent 
airflow, central if it is associated with absent respiratory effort 
throughout the entire period of absent airflow, and mixed if it 
is associated with absent respiratory effort in the initial portion 
of the event, followed by resumption of respiratory effort in the 
second portion of the event. A hypopnea is scored if the follow-
ing criteria are met: the nasal pressure signal excursions drop 
by ≥ 30% of baseline, there is a ≥ 4% desaturation from pre-
event baseline, and at least 90% of the event’s duration meets 
the amplitude reduction criteria. The computer-derived oxygen 
desaturation index (ODI), defined as the number of oxygen de-
saturations ≥ 4% per h of sleep, was also obtained. All scor-
ers recorded the following variables for each PSG: total sleep 
time (TST); min Stages N1, N2, N3, nonrapid eye movement 
(NREM) and Stage R (rapid eye movement, REM); arousal in-
dex; AHI; number of apneas; number of obstructive, central, 
and mixed apneas; number of hypopneas; and ODI. Scoring of 
sleep stages and arousals all followed the new AASM guide-
lines.3 Using the local scoring software available at each site, 
the epoch-by-epoch sleep stage scoring of each PSG was ex-
ported into a text file and then compiled into a Microsoft Ex-
cel spreadsheet by a sleep scoring quality assurance program 
(QSleep, Victoria, Australia).
Sample Size
The primary outcome for the interrater agreement analysis 
was the intraclass correlation coefficient (ICC) of the AHI. 
Given nine sleep scorers (one at each site), the 15 PSGs had a 
power of 83% to detect an ICC of at least 0.90, assuming a null 
hypothesis of ICC = 0.70.
Statistical Analysis
The interrater reliability measures used to examine the 
agreement among the nine different scorers were the ICC for 
continuous variables (respiratory indices, duration of sleep 
stages, and arousal index) and the kappa (κ) statistic for mul-
tiple raters for the categorical variables (sleep stages). The 
levels of agreement using the ICCs of respiratory indices, dura-
tion of sleep stages, and arousal index were classified as fol-
lows: 0.00-0.25 = little, 0.26-0.49 = low, 0.50-0.69 = moderate, 
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0.70-0.89 = strong, 0.90-1.00 = very strong.6-8 For the κ sta-
tistic for multiple raters, the levels of agreement were classi-
fied as follows: < 0 = no agreement, 0-0.20 = slight agreement, 
0.21-0.40 = fair agreement, 0.41-0.60 = moderate agreement, 
0.61-0.80 = substantial agreement, 0.81-1.0 = almost perfect 
agreement.9 Data analyses were performed using Stata software 
version 12 (StataCorp, LP, College Station, TX).
RESULTS
Respiratory Event Scoring
The scored AHI ranged from 0 to 70.9 events/h of sleep. 
The interscorer agreement of AHI scoring (Table 1) among the 
SAGIC centers was very strong, with an ICC of 0.95 (95% con-
fidence interval [CI] 0.91-0.98). There was strong agreement 
in the scoring of the total number of apneas as well as the total 
number of hypopneas. Table 1 displays the means and the stan-
dard deviations (SD) of the scoring of respiratory events in all 
15 PSGs. One site (sleep center number six) tended to score the 
respiratory events as hypopneas, whereas another (sleep center 
number eight) tended to score the respiratory events as apneas 
(Table 1). The agreement of ODI scoring was also very strong 
with an ICC of 0.97 (95% CI 0.93-0.99).
Figure 1 displays all 15 PSG respiratory event scoring results 
at the different sites. As expected from the ICC values, there 
were more variations in the scoring of the total apneas and hy-
popneas compared with the AHI.
The AHI scores were highly correlated with the ODI scores 
(r = 0.96, P < 0.0001). Using the Bland-Altman method, the 
mean difference between AHI and ODI scores was +2.1 
events/h (limits of agreement: +12.3 and -8.1 events/h).
Sleep Stage Scoring
Table 2 shows the epoch-by-epoch (n = 12,712) agreement in 
scoring Stages W, NREM, and REM sleep among the nine scor-
ers. There was substantial agreement in the scoring of the major 
sleep-wake states with κ = 0.78 (95% CI 0.77-0.78). In Table 3, 
the κ values are shown with NREM sleep separated into differ-
ent stages. The scoring of Stages N1 and N2 showed only fair 
(κ = 0.31) and moderate (κ = 0.60) agreements respectively, 
although there was still substantial agreement in the scoring of 
all sleep stages with κ = 0.63 (95% CI 0.62-0.63).
Table 4 shows the agreement of the sleep stage duration 
(min) and arousal index scoring. There was strong agreement in 
the scoring of the duration of TST, NREM, and REM sleep, but 
little to low agreement in the scoring of the duration of Stage 
N1 and N2. There was moderate agreement in the scoring of the 
arousal index with an ICC of 0.68 (95% CI: 0.49-0.85).
DISCUSSION
This study investigated the agreement of scoring respira-
tory events and sleep stages, among experienced scorers using 
the AASM definitions, in nine international sites (members of 
SAGIC). The major findings of this study are: (1) there is a very 
Table 1—Interscorer reliability of respiratory events
Sleep Center (mean)
Variable 1 2 3 4 5 6 7 8 9 ICC 95%CI
AHI (events/h) 25.8 ± 19.4 22.7 ± 18.4 25.7 ± 19.0 25.9 ± 19.8 24.3 ± 17.2 22.7 ± 17.4 23.0 ± 15.4 25.9 ± 21.3 23.6 ± 18.1 0.95 0.91-0.98
Total Apneas 54.1 ± 71.9 31.6 ± 68.2 45.3 ± 66.5 46.3 ± 63.9 42.3 ± 60.3 20.3 ± 41.8 58.1 ± 78.3 104.6 ± 127.7 51.1 ± 72.4 0.73 0.55-0.88
Obstructive 44.1 ± 61.3 28.7 ± 68.2 39.5 ± 67.1 35.9 ± 55.2 37.5 ± 57.1 17.7 ± 36.7 56.4 ± 76.6 100.7 ± 127.7 42.2 ± 68.9 0.70 0.51-0.86
Central 6.7 ± 9.1 2.9 ± 7.1 4.4 ± 7.8 7.3 ± 10.2 1.0 ± 2.0 0.9 ± 1.4 0.9 ± 1.9 3.3 ± 6.2 6.7 ± 7.8 0.46 0.27-0.70
Mixed 3.3 ± 9.5 0.1 ± 0.3 1.5 ± 3.0 3.1 ± 7.5 4.0 ± 7.5 1.7 ± 5.4 0.8 ± 2.3 0.6 ± 1.2 2.2 ± 5.6 0.42 0.24-0.67
Hypopneas 90.1 ± 76.6 100.7 ± 85.7 109.1 ± 85.4 94.8 ± 73.8 108.2 ± 79.4 109.2 ± 87.4 81.1 ± 58.1 51.0 ± 36.9 86.5 ± 75.1 0.80 0.65-0.91
ODI (events/h) 22.4 ± 17.6 22.0 ± 17.5 24.6 ± 18.3 21.6 ± 17.0 25.3 ± 17.5 22.4 ± 18.0 19.7 ± 14.2 22.9 ± 17.4 20.9 ± 16.6 0.97 0.93-0.99
AHI, apnea-hypopnea index; CI, confidence interval; ICC, intraclass correlation coefficient; ODI, oxygen desaturation index.
Table 2—Kappa (κ) statistics evaluating epoch-by epoch sleep staging (NREM combined)
W NREM REM All stages Number of epochs
κ 0.78 0.77 0.78 0.78
12,712
95% CI 0.77-0.79 0.76-0.78 0.77-0.79 0.77-0.78
CI, confidence interval; NREM, nonrapid eye movement; REM, rapid eye movement.
Table 3—Kappa (κ) statistics evaluating epoch-by-epoch staging (NREM separated)
W N1 N2 N3 R All stages Number of epochs
κ 0.78 0.31 0.60 0.67 0.78 0.63
12,712
95% CI 0.77-0.79 0.30-0.32 0.59-0.61 0.65-0.69 0.77-0.79 0.62-0.63
CI, confidence interval; NREM, nonrapid eye movement.
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Figure 1—The absolute values of the respiratory event scoring of each of the 15 polysomnographs in the different Sleep Apnea Genetics International 
Consortium centers are shown. As expected from the intraclass correlation coefficient values, there were more variations in the scoring of the total apneas 
and hypopneas compared with the apnea-hypopnea index (AHI).
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strong agreement in the scoring of the AHI among experienced 
sleep technologists using the AASM recommended defini-
tions of respiratory events; (2) there is strong agreement in the 
scoring of the total number of apneas and hypopneas; and (3) 
there is substantial epoch-by-epoch agreement in scoring wake, 
NREM, and REM sleep. The computer-assisted scoring of the 
ODI also showed very strong agreement despite using various 
scoring software to derive this index. To our knowledge, this 
is the first study examining the interscorer agreement of PSG 
scoring of respiratory events and sleep among international 
sleep centers based on the 2007 AASM guidelines. The issue of 
agreement is not only important to researchers who are planning 
multicenter collaborative efforts but also to clinicians because 
such information is essential for evaluation of the findings and 
interpretation. The use of different scoring software across the 
nine centers is a strength of this study as it provides a greater 
challenge to good agreement and is a real-world application.
A previous study reported by Whitney and colleagues5 
showed that the interrater agreement of scoring respiratory 
indices by three sleep technologists at one centralized scoring 
center was excellent when respiratory indices were defined in 
association with an oxyhemoglobin desaturation rather than the 
presence of associated EEG arousals. Our study extends this 
finding to international sleep centers and showed that using the 
2007 AASM recommended scoring guidelines (which bases the 
hypopnea definition on the occurrence of a ≥ 4% oxyhemoglo-
bin desaturation), there is very strong agreement in AHI scoring 
(ICC = 0.95; 95% CI 0.91-0.98). This is similar to the ICC of 
0.99 (95% CI not reported) in the prior study of three scorers 
using the same hypopnea definition.5 In our current study, the 
agreement in the scoring of central and mixed apneas was lower 
than obstructive apneas with an ICC of 0.46 and 0.42, respec-
tively. The reasons for these findings are unclear, but suggest 
that it is an area that needs to be emphasized in ongoing quality 
improvement of PSG scoring among the SAGIC centers.
We also found similar levels of agreement in regard to sleep 
stage scoring with a previously reported κ of 0.81-0.83 among 
two scorers in the study by Whitney et al.5 compared with the κ 
of 0.78 observed among the nine scorers in our study. It should 
be pointed out that this previous study used the Rechtshaffen 
and Kales (R & K) criteria in scoring sleep stages because it 
was conducted prior to the publication of the 2007 AASM scor-
ing guidelines. With regard to sleep staging, our results indi-
cated that the lowest agreement is in the scoring of Stage N1, a 
finding also reported in the study by Whitney et al. The interra-
ter agreement of sleep stage scoring was also previously exam-
ined by Danker-Hopfe and colleagues4 in 12 PSGs among six 
scorers from three sleep centers located in Austria and Germa-
ny. These investigators found a substantial agreement in sleep 
stage scoring using the AASM guidelines (0.61 < κ < 0.80) and 
their study suggested that the interrater agreement was higher 
when using the AASM guidelines compared with the R & K 
criteria. In addition, they also found the lowest agreement in 
Stage N1 scoring. Unlike our study, however, these investiga-
tors also found a low interrater agreement in Stage N3 scoring.
Our study has some limitations. First, we only included one 
experienced scorer at each site. Additional research would be 
needed to determine PSG scoring agreement if multiple scorers 
from each center would be involved in SAGIC research proj-
ects. Second, we did not determine the intrascorer reliability 
of respiratory event and PSG scoring. Nonetheless, the previ-
ous study by Whitney and colleagues5 suggests that intrascorer 
agreement of respiratory indices and sleep staging was also ex-
cellent. Third, the 15 PSGs used in this study were attended, 
in-laboratory sleep studies performed in one member center. 
However, data acquisition in these PSGs used standard tech-
niques that would not be expected to be different given the 
equipment used at the nine SAGIC sites. It is not clear whether 
our findings can be generalized to unattended PSGs. Fourth, 
we did not examine the scoring of periodic limb movements 
because our aim was primarily to assess the interrater agree-
ment of scoring of respiratory indices and sleep stages. Finally, 
our current findings should be viewed within the context of new 
AASM respiratory scoring rules that will soon be published that 
call for a change in hypopnea definition and stipulate the fol-
lowing: a drop of peak signal excursion by ≥ 30% of pre-event 
baseline using the nasal pressure signal for a duration of ≥ 10 
sec with a ≥ 3% oxygen desaturation from pre-event baseline or 
an associated arousal. The effect of the upcoming change in hy-
popnea definition (which incorporates the presence of arousals) 
on the interrater reliability of scoring respiratory events among 
international centers is yet to be examined.
There are several key implications in research collaboration 
continuing from the results of this important study. Although 
there was very strong agreement in the scoring of the AHI, one 
site (sleep center number six) tended to score the respiratory 
events as hypopneas, whereas another (sleep center number 
eight) tended to score the respiratory events as apneas (Table 1). 
Table 4—Interscorer reliability of sleep stage duration and arousal index
Sleep Center (mean)
Variable 1 2 3 4 5 6 7 8 9 ICC 95%CI
TST 342.2 ± 51.6 355.7 ± 46.7 365.2 ± 43.8 336.3 ± 54.5 362.3 ± 44.7 347.4 ± 51.9 370.8 ± 48.7 367.6 ± 45.3 352.2 ± 48.9 0.88 0.76-0.95
NREM 298.3 ± 43.7 301.7 ± 36.6 313.8 ± 35.3 289.7 ± 45.8 318.9 ± 37.7 300.2 ± 42.8 328.7 ± 41.5 297.1 ± 33.6 288.0 ± 42.2 0.77 0.59-0.90
Stage N1 59.2 ± 26.1 35.2 ± 20.4 31.8 ± 17.8 38.8 ± 14.1 43.8 ± 24.7 110.9 ± 43.6 44.4 ± 19.1 55.6 ± 29.4 61.3 ± 25.1 0.21 0.08-0.45
Stage N2 200.7 ± 44.5 238.3 ± 41.1 231.2 ± 26.3 192.9 ± 36.2 210.6 ± 31.5 164.0 ± 58.3 211.7 ± 41.1 180.9 ± 42.3 191.2 ± 39.3 0.41 0.22-0.66
Stage N3 38.4 ± 30.8 28.2 ± 29.8 50.8 ± 37.6 58.0 ± 40.2 64.5 ± 36.3 25.4 ± 18.5 72.6 ± 61.2 60.5 ± 32.2 35.4 ± 26.8 0.62 0.40-0.82
REM 43.9 ± 22.3 54.0 ± 26.8 51.5 ± 29.3 46.6 ± 22.8 43.4 ± 22.8 47.9 ± 26.9 42.0 ± 25.9 70.5 ± 31.2 64.3 ± 31.2 0.78 0.59-0.91
Arousal Index 
(events/h)
38.0 ± 16.4 30.2 ± 19.4 25.9 ± 17.7 35.1 ±18.0 19.9 ± 11.0 25.4 ± 16.3 22.5 ± 16.1 30.9 ± 18.0 26.3 ± 16.6 0.68 0.49-0.85
CI, confidence interval; ICC, intraclass correlation coefficient; NREM, nonrapid eye movement; REM, rapid eye movement; TST, total sleep time.
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We also found lower levels of agreement in the scoring of spe-
cific NREM sleep stages, particularly stage N1 (Table 3). Find-
ings from this initial project will help in the ongoing quality 
improvement of PSG scoring among the SAGIC centers be-
cause they suggest that efforts in scoring education among the 
sleep technologists should be centered on the differentiation be-
tween apneas and hypopneas, identification of central apneas, 
and improving recognition of sleep stage N1.
OSA is a highly prevalent condition not only in Western 
countries but also worldwide.10-12 The condition is associated 
with a variety of adverse consequences including hypertension, 
stroke, cardiovascular disease, and motor vehicle crashes.13-16 
There is a growing interest in performing multicenter studies 
involving patients with OSA at the international level.17 Cen-
tralized scoring of PSGs in multicenter studies involving dif-
ferent countries in various continents will require a greater 
magnitude of resources that may not always be available to 
investigators. An alternative approach would be scoring of the 
sleep studies locally in the sleep centers where the PSGs are 
acquired. Our results suggest that this is feasible in future re-
search collaboration among national and international groups 
such as SAGIC, particularly in studies where the AHI, ODI, 
and duration of sleep are the primary variables of interest. Addi-
tional steps required to ensure standardization of data collection 
would include ensuring similar procedures (such as sampling 
rates and filters) and comparable pulse oximeters18 are used at 
each center, and technically adequate signals are obtained dur-
ing the data acquisition of PSGs.
In summary, our findings show a substantial agreement in the 
scoring of the respiratory events as well as sleep stages among 
international sleep centers working in the SAGIC consortium 
using the 2007 AASM guidelines where experienced sleep 
technologists are involved. Our results suggest an alternative 
approach to centralized scoring of PSGs in research collabora-
tion among national and international centers, particularly if the 
AHI, TST, and ODI are the primary variables of interest. This 
approach could be used in multicenter studies providing a simi-
lar scoring validation is conducted.
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